Stay tuned
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for phar
More info, please: FTC sends Amgen, Horizon a second request for info as it looks over proposed merger
More info, please: FTC sends Amgen, Horizon a second request for info
Novartis' Zolgensma, Leqvio lag among new launches as Entresto and Pluvicto steam ahead
Novartis' Zolgensma, Leqvio lag among new launches as Entresto and Pl
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex k
Amgen aims to make the most of Amjevita's head start amid broader biosim lull, Lumakras miss
Amgen aims to make the most of Amjevita's head start amid broader bio
Stay tuned
© 1994 - 2023 B.M. Pharmaceuticals